These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9414019)
1. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET. Schlösser R; Brodie JD; Dewey SL; Alexoff D; Wang GJ; Fowler JS; Volkow N; Logan J; Wolf AP Synapse; 1998 Jan; 28(1):66-70. PubMed ID: 9414019 [TBL] [Abstract][Full Text] [Related]
2. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. Volkow ND; Fowler JS; Wang GJ; Dewey SL; Schlyer D; MacGregor R; Logan J; Alexoff D; Shea C; Hitzemann R J Nucl Med; 1993 Apr; 34(4):609-13. PubMed ID: 8455077 [TBL] [Abstract][Full Text] [Related]
3. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. Logan J; Volkow ND; Fowler JS; Wang GJ; Dewey SL; MacGregor R; Schlyer D; Gatley SJ; Pappas N; King P J Cereb Blood Flow Metab; 1994 Nov; 14(6):995-1010. PubMed ID: 7929663 [TBL] [Abstract][Full Text] [Related]
4. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis. Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776 [TBL] [Abstract][Full Text] [Related]
5. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632 [TBL] [Abstract][Full Text] [Related]
6. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. Wang GJ; Volkow ND; Fowler JS; Logan J; Pappas NR; Wong CT; Hitzemann RJ; Netusil N J Nucl Med; 1999 Aug; 40(8):1285-91. PubMed ID: 10450679 [TBL] [Abstract][Full Text] [Related]
7. Distribution volume ratios without blood sampling from graphical analysis of PET data. Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228 [TBL] [Abstract][Full Text] [Related]
8. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique. Ito H; Okubo Y; Halldin C; Farde L Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552 [TBL] [Abstract][Full Text] [Related]
9. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624 [TBL] [Abstract][Full Text] [Related]
10. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051 [TBL] [Abstract][Full Text] [Related]
11. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. Dewey SL; Smith GS; Logan J; Brodie JD; Yu DW; Ferrieri RA; King PT; MacGregor RR; Martin TP; Wolf AP J Neurosci; 1992 Oct; 12(10):3773-80. PubMed ID: 1357114 [TBL] [Abstract][Full Text] [Related]
12. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281 [TBL] [Abstract][Full Text] [Related]
13. A new PET ligand for the dopamine transporter: studies in the human brain. Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098 [TBL] [Abstract][Full Text] [Related]
14. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Breier A; Adler CM; Weisenfeld N; Su TP; Elman I; Picken L; Malhotra AK; Pickar D Synapse; 1998 Jun; 29(2):142-7. PubMed ID: 9593104 [TBL] [Abstract][Full Text] [Related]
15. Comparison of methods for analysis of clinical [11C]raclopride studies. Lammertsma AA; Bench CJ; Hume SP; Osman S; Gunn K; Brooks DJ; Frackowiak RS J Cereb Blood Flow Metab; 1996 Jan; 16(1):42-52. PubMed ID: 8530554 [TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis. Farde L; Eriksson L; Blomquist G; Halldin C J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555 [TBL] [Abstract][Full Text] [Related]
17. Evidence for striatal dopamine release during a video game. Koepp MJ; Gunn RN; Lawrence AD; Cunningham VJ; Dagher A; Jones T; Brooks DJ; Bench CJ; Grasby PM Nature; 1998 May; 393(6682):266-8. PubMed ID: 9607763 [TBL] [Abstract][Full Text] [Related]
18. Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. Yoder KK; Wang C; Morris ED J Nucl Med; 2004 May; 45(5):903-11. PubMed ID: 15136642 [TBL] [Abstract][Full Text] [Related]
19. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain. Ginovart N; Farde L; Halldin C; Swahn CG Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390 [TBL] [Abstract][Full Text] [Related]
20. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Volkow ND; Wang GJ; Fowler JS; Logan J; Schlyer D; Hitzemann R; Lieberman J; Angrist B; Pappas N; MacGregor R Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]